[
  {
    "pmid": "41160711",
    "title": "Micro-Sim: Advancing antimicrobial Stewardship education through interprofessional simulation.",
    "authors": "Vella M, Choo LL, Lodhi I",
    "year": 2025,
    "journal": "Medical teacher",
    "abstract": "Inappropriate antibiotic prescribing remains a persistent problem, with significant knowledge gaps among students and physicians. We evaluated 180 antibiotic prescriptions showing 68% were inconsistent with trust guidelines, highlighting the need for targeted interventions.\nParticipants undertook a week-long program comprising interactive presentations, charts, newsletters, and the Micro-Sim simulation. Acting as infection doctors, they managed bleeps and advised on ten structured cases including assessing a septic mannikin. Pre- and postintervention questionnaires assessed knowledge, supplemented by qualitative feedback.\nAcross 10 sessions (\nWe plan to train regional facilitators and develop a virtual version of Micro-Sim to enable international dissemination.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41160711/",
    "doi": "10.1080/0142159X.2025.2579098"
  },
  {
    "pmid": "41153807\n39771976\n25921609\n40244306\n40225437\n39842547\n39017735\n40301180\n35249211\n40327340\n39641393\n39066819\n31656032\n38797797\n38367812\n40281402\n38289911\n37265424\n39680885\n39541631\n31978628\n40148464\n38965513\n39408177\n27765959\n30617335\n32346050\n38273257\n31501885\n40241963\n28481991\n30617339\n40592734\n19072244\n26246167\n37682491\n38968031\n39854695\n31965266\n37588623\n40567322\n40115064\n40416709\n37160649\n37862082\n39369796\n40305830\n20978258\n40036494\n40055665\n35326921\n38448409\n35351674\n40533820\n31128285\n40379137\n26947174\n40235844\n39757287\n39458286\n39906157\n40286586\n33676936\n38636331\n39803892\n39233995\n32328883\n29435343\n37054749\n40674049\n39852795\n34310796\n38908399\n39386390\n25680492\n36040741\n40292837\n35337644\n35200334\n31162915\n40415092\n40001378\n30943338\n38124256\n39671580\n36107486\n40499968\n38265640\n39970690\n31537911\n31022749\n33323236\n40529344\n40613579",
    "title": "Artificial Intelligence in the Management of Infectious Diseases in Older Adults: Diagnostic, Prognostic, and Therapeutic Applications.",
    "authors": "Pinto A, Pennisi F, Odelli S, De Ponti E, Veronese N, Signorelli C, Baldo V, Gianfredi V",
    "year": 2025,
    "journal": "Biomedicines",
    "abstract": "",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41153807\n39771976\n25921609\n40244306\n40225437\n39842547\n39017735\n40301180\n35249211\n40327340\n39641393\n39066819\n31656032\n38797797\n38367812\n40281402\n38289911\n37265424\n39680885\n39541631\n31978628\n40148464\n38965513\n39408177\n27765959\n30617335\n32346050\n38273257\n31501885\n40241963\n28481991\n30617339\n40592734\n19072244\n26246167\n37682491\n38968031\n39854695\n31965266\n37588623\n40567322\n40115064\n40416709\n37160649\n37862082\n39369796\n40305830\n20978258\n40036494\n40055665\n35326921\n38448409\n35351674\n40533820\n31128285\n40379137\n26947174\n40235844\n39757287\n39458286\n39906157\n40286586\n33676936\n38636331\n39803892\n39233995\n32328883\n29435343\n37054749\n40674049\n39852795\n34310796\n38908399\n39386390\n25680492\n36040741\n40292837\n35337644\n35200334\n31162915\n40415092\n40001378\n30943338\n38124256\n39671580\n36107486\n40499968\n38265640\n39970690\n31537911\n31022749\n33323236\n40529344\n40613579/",
    "doi": "10.3390/biomedicines13102525\n10.3390/vaccines12121314\n10.1007/s10522-015-9578-8\n10.1007/s40520-025-03021-8\n10.7759/cureus.80442\n10.1007/174_2024_558\n10.1016/j.cmi.2025.01.009\n10.1007/s40520-024-02808-5\n10.1007/s40520-025-03050-3\n10.1007/s40520-022-02094-z\n10.1001/jamanetworkopen.2025.8867\n10.1002/cam4.70426\n10.1007/s40520-024-02798-4\n10.1007/s40520-019-01375-4\n10.1007/s40520-024-02772-0\n10.1016/j.arr.2024.102237\n10.1186/s12875-025-02836-8\n10.1093/gerona/glad279\n10.1002/14651858.CD014885.pub2\n10.1002/widm.1485\n10.2196/60794\n10.48550/arXiv.2507.14912\n10.1016/j.gerinurse.2024.10.078\n10.4103/jiag.jiag_67_24\n10.1016/j.psychres.2019.112732\n10.1038/s41598-025-95604-8\n10.1186/s12889-024-19096-3\n10.3390/healthcare12191996\n10.1109/JPROC.2015.2501978\n10.1038/s41591-018-0316-z\n10.48550/arXiv.1711.05225\n10.1038/s41598-020-62922-y\n10.1186/s12874-023-02138-6\n10.1093/bioinformatics/btz682\n10.3389/fpubh.2025.1547450\n10.1093/bib/bbx044\n10.1016/j.inffus.2017.10.006\n10.1038/s41591-018-0300-7\n10.1136/bmjment-2025-301733\n10.1086/595683\n10.1126/scitranslmed.aab3719\n10.1108/TECHS-12-2021-0029\n10.1007/s40520-023-02552-2\n10.3233/THC-240087\n10.2196/56155\n10.1007/s00134-019-05872-y\n10.1016/j.eclinm.2023.102124\n10.5005/jp-journals-10071-24986\n10.21037/atm-24-150\n10.2147/JIR.S502837\n10.1007/s40520-023-02409-8\n10.2196/47346\n10.1016/j.arr.2024.102529\n10.2196/67437\n10.1001/jama.2010.1553\n10.2196/66699\n10.1186/s12911-025-02953-5\n10.3390/healthcare10030443\n10.1021/acsphotonics.0c00841\n10.1038/s41467-024-46211-0\n10.1016/j.jgar.2022.03.019\n10.1186/s12967-025-06488-1\n10.1016/j.cmi.2019.05.013\n10.1016/j.idnow.2025.105090\n10.1016/j.artmed.2016.02.001\n10.1007/s13205-025-04282-w\n10.1007/s10096-024-05027-y\n10.3390/microorganisms12101978\n10.1016/j.csbj.2025.01.006\n10.1016/j.sajce.2024.12.005\n10.1016/j.artmed.2025.103137\n10.1016/j.jhin.2021.02.025\n10.1016/j.compbiomed.2024.108469\n10.2196/58509\n10.46234/ccdcw2024.192\n10.1007/s11517-020-02165-1\n10.1136/bmjresp-2017-000234\n10.3390/electronics11050673\n10.1016/j.jamda.2023.03.005\n10.1001/jamanetworkopen.2025.21785\n10.3390/vaccines13010016\n10.1111/acem.14357\n10.1016/j.jamda.2024.105080\n10.3389/fdgth.2024.1441334\n10.1016/j.cnur.2014.10.010\n10.1001/jamanetworkopen.2022.29067\n10.3390/s25061735\n10.1016/S2589-7500(21)00276-4\n10.3390/bios12020073\n10.1038/s41598-025-03332-w\n10.3390/antibiotics14020134\n10.1056/NEJMra1814259\n10.1093/ageing/afad219\n10.2196/63710\n10.2196/38144\n10.1136/bmjopen-2024-096669\n10.7416/ai.2024.2597\n10.1016/j.cmpb.2025.108653\n10.1038/s41591-019-0609-x\n10.1055/s-0039-1677902\n10.1016/S2589-7500(19)30002-0\n10.2147/IJGM.S516247\n10.17305/bb.2025.12378"
  },
  {
    "pmid": "41150080\n38797176\n38331529\n38262139\n40338404\n38800841\n36978354\n36605768\n30895209\n40093312\n7376378\n33960495\n33509339\n40135877\n39435404\n36185800\n35271460",
    "title": "Veterinarians' Perspectives on the Antimicrobial Resistance (AMR) Dashboard: A Survey of Needs and Preferences to Inform Development.",
    "authors": "Pellissery AJ, Denagamage T, Pedersen M, Kariyawasam S",
    "year": 2025,
    "journal": "Veterinary sciences",
    "abstract": "Antimicrobial resistance (AMR) poses a significant global threat to human and animal health, necessitating robust surveillance and stewardship tools. While existing systems address aspects of veterinary AMR, a comprehensive, user-centric dashboard for U.S. veterinarians remains a critical unmet need. This study aimed to identify U.S. veterinarians' preferences and perceived needs for such a dashboard, to help guide its design and development. A cross-sectional survey was conducted between January and March 2024, targeting U.S. veterinarians through professional channels. The survey instrument captured demographics, experiences with existing tools, preferences for data types and visualizations, desired technical specifications, and open-ended feedback. Of the 677 respondents, a near-unanimous consensus (over 75%) emerged on the importance of functionalities like antimicrobial stewardship education, off-label use guidance, surveillance data, and empirical treatment support. Over 70% expressed comfort sharing aggregated geographic and de-identified animal data. A strong preference was observed for making the dashboard accessible by veterinary colleges (78.87%), diagnostic laboratories (72.61%), and federal agencies (USDA: 71.47%, CDC: 66.67%, FDA: 62.11%), indicating a desire for a collaborative, authoritative system. The findings provide a robust foundation for developing a U.S. veterinary AMR dashboard. Future phases should adopt an iterative, user-centered design, incorporating qualitative research with diverse stakeholders and piloting a prototype with preferred institutional partners. This approach will ensure a trusted, sustainable tool that effectively translates surveillance data into actionable insights for improved animal and public health.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41150080\n38797176\n38331529\n38262139\n40338404\n38800841\n36978354\n36605768\n30895209\n40093312\n7376378\n33960495\n33509339\n40135877\n39435404\n36185800\n35271460/",
    "doi": "10.3390/vetsci12100940\n10.1016/S0140-6736(24)00876-6\n10.1016/S2542-5196(23)00278-4\n10.2460/ajvr.23.12.0294\n10.1007/s11259-025-10752-6\n10.1089/vbz.2023.0167\n10.3390/antibiotics12030487\n10.3389/fvets.2022.1068406\n10.1093/ofid/ofy346\n10.12688/wellcomeopenres.21010.4\n10.1136/vr.106.12.260\n10.1002/vetr.477\n10.2807/1560-7917.ES.2021.26.4.2001359\n10.1128/aac.01657-24\n10.3389/fpubh.2024.1411962\n10.2460/JAVMA.21.09.0431"
  },
  {
    "pmid": "41148730\n36101788\n28178770\n29962311\n37614960\n33571265\n30764777\n28524255\n28385463\n25439025\n23572483\n21602488\n27139474\n34301332\n40070317\n24200831\n37616423\n26643196\n34601148\n39406042\n33271843\n38320516\n33813115\n25813839\n16235325\n39659641\n39295113\n17872937\n31078660\n18929686",
    "title": "Barriers and Enablers to Optimal Antimicrobial Use in Respiratory Tract Infections.",
    "authors": "Reali S, Cho JG, Alffenaar JW, Aslani P",
    "year": 2025,
    "journal": "Antibiotics (Basel, Switzerland)",
    "abstract": "",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41148730\n36101788\n28178770\n29962311\n37614960\n33571265\n30764777\n28524255\n28385463\n25439025\n23572483\n21602488\n27139474\n34301332\n40070317\n24200831\n37616423\n26643196\n34601148\n39406042\n33271843\n38320516\n33813115\n25813839\n16235325\n39659641\n39295113\n17872937\n31078660\n18929686/",
    "doi": "10.3390/antibiotics14101039\n10.1183/23120541.00113-2022\n10.1002/14651858.CD003543.pub4\n10.1177/0300060518782519\n10.1093/jacamr/dlad100\n10.1371/journal.pone.0246782\n10.1186/s12875-019-0917-8\n10.1111/ijcp.12959\n10.1016/j.ajic.2017.03.003\n10.1111/ijcp.12538\n10.1093/cid/cit212\n10.1177/0272989X11406985\n10.1128/AAC.00209-16\n10.1186/s13690-021-00624-1\n10.1002/bcp.70011\n10.1093/cid/cit578\n10.3109/02813432.2015.1114348\n10.1016/j.cmi.2021.09.025\n10.1016/j.diagmicrobio.2024.116541\n10.3390/antibiotics9120859\n10.1056/EVIDtt2300234\n10.1016/j.cmi.2021.03.030\n10.1586/14787210.2015.1025057\n10.1002/14651858.cd003539.pub2\n10.1093/jacamr/dlae192\n10.1093/fampra/cmae047\n10.1093/intqhc/mzm042\n10.1016/j.jbi.2019.103208\n10.1016/j.jbi.2008.08.010\n10.1191/1478088706qp063oa"
  },
  {
    "pmid": "41148676\n35065702\n26603922\n32938614\n25747410\n17446241\n31873263\n26507098\n31150071\n34943671\n30895206\n16902573\n27575599\n29136646\n32436349\n35959211\n35348880\n35089952\n35415610\n38887900\n36992717\n26573236\n36846632\n30045731\n33593725\n34593508\n29102353\n23213162\n29150419\n23673882\n32134603\n31668170\n31049404\n36028271\n33409205\n32273313\n3068205\n17244132\n34827283\n31174524\n26429566",
    "title": "Co-Producing an Intervention to Reduce Inappropriate Antibiotic Prescribing Among Dental Practitioners in India.",
    "authors": "Bhuvaraghan A, Walley J, King R, Aggarwal VR",
    "year": 2025,
    "journal": "Antibiotics (Basel, Switzerland)",
    "abstract": "",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41148676\n35065702\n26603922\n32938614\n25747410\n17446241\n31873263\n26507098\n31150071\n34943671\n30895206\n16902573\n27575599\n29136646\n32436349\n35959211\n35348880\n35089952\n35415610\n38887900\n36992717\n26573236\n36846632\n30045731\n33593725\n34593508\n29102353\n23213162\n29150419\n23673882\n32134603\n31668170\n31049404\n36028271\n33409205\n32273313\n3068205\n17244132\n34827283\n31174524\n26429566/",
    "doi": "10.3390/antibiotics14100984\n10.1016/S0140-6736(21)02724-0\n10.1016/S0140-6736(15)00473-0\n10.1136/bmjgh-2020-003393\n10.1093/cid/civ076\n10.1093/jac/dkm090\n10.1038/s41415-019-1002-3\n10.1111/cdoe.12199\n10.1001/jamanetworkopen.2019.3909\n10.3390/antibiotics10121459\n10.1093/ofid/ofz067\n10.1038/sj.bdj.4813879\n10.1371/journal.pmed.1002115\n10.1371/journal.pone.0188061\n10.1111/bcp.14373\n10.1093/ofid/ofac361\n10.1007/s00784-022-04453-6\n10.1371/journal.pone.0262731\n10.1093/jacamr/dlac039\n10.1111/cdoe.12989\n10.1016/j.ssmph.2023.101378\n10.1136/jech-2015-205952\n10.1016/j.worlddev.2022.105889\n10.1186/s12961-018-0344-7\n10.1136/bmj.n166\n10.1136/bmj.n2061\n10.1016/S2214-109X(17)30383-2\n10.1377/hlthaff.2011.1356\n10.1136/bmj.j5147\n10.1097/QAI.0b013e3182920286\n10.1016/j.adaj.2019.08.020\n10.3399/bjgpopen18X101617\n10.1136/bmjopen-2021-060304\n10.1136/bmjopen-2019-033516\n10.18332/pht/189989\n10.1177/109019818801500401\n10.1111/j.1600-0528.2007.00348.x\n10.3390/antibiotics10111345\n10.1186/s12909-019-1623-x\n10.1093/jac/dkv336"
  },
  {
    "pmid": "41148668\n39415207\n35065702\n39816255\n38476862\n37175597\n25060972\n40001376\n35616940\n37628504\n35694248\n26852795\n37038124\n35745632\n37467239\n38166736\n40426545\n39415487\n40325130\n38927144\n36309348\n38105789\n35912421\n40462148\n10585974\n25220798\n37206057\n39882210\n40080812\n33741531\n26582868\n38247629\n36830137\n33622432\n28712667\n37189584\n37372411\n40470160\n32948060\n31189642\n39305917",
    "title": "Antibiotic Use in Pediatrics: Perceptions and Practices of Romanian Physicians.",
    "authors": "Iuhas A, Gali\u0219 R, Rus M, Petche\u0219i CD, Balmo\u0219 A, Marin\u0103u C, Niula\u0219 L, Futaki Z, Matioc D, Sava C",
    "year": 2025,
    "journal": "Antibiotics (Basel, Switzerland)",
    "abstract": "",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41148668\n39415207\n35065702\n39816255\n38476862\n37175597\n25060972\n40001376\n35616940\n37628504\n35694248\n26852795\n37038124\n35745632\n37467239\n38166736\n40426545\n39415487\n40325130\n38927144\n36309348\n38105789\n35912421\n40462148\n10585974\n25220798\n37206057\n39882210\n40080812\n33741531\n26582868\n38247629\n36830137\n33622432\n28712667\n37189584\n37372411\n40470160\n32948060\n31189642\n39305917/",
    "doi": "10.3390/antibiotics14100976\n10.1186/s12992-024-01046-8\n10.1016/S0140-6736(21)02724-0\n10.3389/frabi.2024.1439688\n10.1155/2024/9958678\n10.3390/ijms24097892\n10.1099/jmm.0.074039-0\n10.1001/jamanetworkopen.2022.14153\n10.3390/healthcare11162307\n10.3389/fphar.2022.890398\n10.3399/bjgp16X683821\n10.1186/s12875-023-02047-z\n10.3390/ph15060713\n10.1371/journal.pone.0288480\n10.1186/s12875-023-02223-1\n10.3390/antibiotics14050479\n10.1111/jep.14173\n10.1038/s41598-025-99642-0\n10.3390/antibiotics13060477\n10.21873/invivo.13019\n10.3389/fped.2023.1289256\n10.3238/arztebl.m2022.0275\n10.1186/s13049-025-01415-1\n10.1542/peds.104.6.1251\n10.1016/j.anpede.2015.05.009\n10.1177/20499361231169429\n10.3389/fped.2024.1546387\n10.2196/60831\n10.1016/j.acap.2021.03.008\n10.1093/jpids/piu086\n10.3390/antibiotics13010070\n10.3390/antibiotics12020224\n10.1017/ice.2021.21\n10.1016/j.cmi.2017.07.010\n10.3390/diagnostics13081483\n10.3390/genes14061231\n10.2147/JMDH.S512254\n10.3390/antibiotics9090610\n10.1016/S2214-109X(24)00382-6"
  },
  {
    "pmid": "41148659\n20857804\n23327981\n10580626\n35731268\n6386263\n23057476\n28467526\n24799638\n28427474\n33957917\n28993891\n31017647\n11821511\n21653301\n20517290\n18662118\n10219875\n22455271\n28723736\n19561486\n19995312",
    "title": "Antimicrobial Prophylaxis in Elective Orthopaedic Surgical Procedures at the Tertiary Care Hospital: A Prospective Observational Study.",
    "authors": "Kosi\u0107 M, Miljkovi\u0107 B, Bari\u0161i\u0107 V, Vezmar-Kova\u010devi\u0107 S, Jovanovi\u0107 M, Vu\u010di\u0107evi\u0107 K, Kova\u010devi\u0107 T",
    "year": 2025,
    "journal": "Antibiotics (Basel, Switzerland)",
    "abstract": "",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41148659\n20857804\n23327981\n10580626\n35731268\n6386263\n23057476\n28467526\n24799638\n28427474\n33957917\n28993891\n31017647\n11821511\n21653301\n20517290\n18662118\n10219875\n22455271\n28723736\n19561486\n19995312/",
    "doi": "10.3390/antibiotics14100968\n10.2146/ajhp120568\n10.1086/501577\n10.1017/ice.2020.497\n10.1007/s00268-022-06621-x\n10.1111/j.1445-2197.2012.06143.x\n10.1001/jamasurg.2017.0904\n10.1086/676022\n10.1186/s13104-017-2475-2\n10.1186/s12891-021-04290-w\n10.1007/s00132-017-3486-3\n10.1001/jamasurg.2019.0569\n10.1056/NEJMcp011603\n10.1093/cid/cir301\n10.1038/nrneph.2010.71\n10.1586/14787210.6.4.523\n10.1086/501620\n10.1097/MD.0000000000006903\n10.1097/SLA.0b013e3181ad5fca\n10.3109/17453670903316868"
  },
  {
    "pmid": "41145199\n35929641\n35065702\n33789754\n38008421\n31157116\n26603922\n34222945\n28893183\n15207010\n34641903\n38362471\n36872455\n21465929\n31881071\n32408900\n27429495\n36604393\n33318116\n20021682\n36651403\n38661290\n34104272\n28458801\n30178033\n26704633\n33588842\n33142711\n32669092\n36830154\n34879697\n36290076\n39159269\n27567604\n34416911\n16168785\n38457130\n38582533\n30115074\n28178770\n33072690",
    "title": "Involvement of community health workers in antimicrobial stewardship interventions and programmes: a scoping review.",
    "authors": "Castro-S\u00e1nchez E, Huguet-Torres A, Y\u00e1\u00f1ez-Juan AM, Bennasar-Veny M",
    "year": 2025,
    "journal": "BMJ global health",
    "abstract": "Antimicrobial resistance (AMR) poses a global health threat, especially in low-income and middle-income countries. Community health workers (CHWs) are key actors in infection management and health promotion; however, their involvement in antimicrobial stewardship (AMS) remains unclear. This study aims to assess CHWs' roles in AMS, examine their training and support, and evaluate outcomes regarding antibiotic use and resistance.\nA scoping review was conducted to explore the roles, education, training and antimicrobial-related outcomes of CHWs. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines, with the protocol registered in Open Science Framework. Databases including PubMed, EMBASE and CINAHL were searched for studies published in English and Spanish. A narrative synthesis was applied to the identified articles, with the Integrated Quality Criteria for the Review of Multiple Study Designs and Quality Assessment Tool for Studies with Diverse Designs tools employed to assess the risk of bias.\nEight studies were identified, conducted in Uganda, Tanzania, Zambia, Pakistan, Bangladesh and Kenya. CHWs were involved in various AMS activities, such as infection prevention, detection and treatment of conditions such as pneumonia and gastrointestinal infections. CHWs contributed to health education, antibiotic prescription (when authorised) and improved adherence to guidelines. Positive outcomes included reduced inappropriate antibiotic use and increased community awareness of AMR. However, the effectiveness of these interventions varied depending on the local context and resources.\nCHWs play an important role in promoting responsible antibiotic use and addressing AMR, particularly in underserved settings. Strengthening their training, expanding selected roles and responsibilities and improving support mechanisms should be considered to enhance their potential contribution to AMS programmes. Further research is needed to optimise CHW interventions and evaluate their long-term impact.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41145199\n35929641\n35065702\n33789754\n38008421\n31157116\n26603922\n34222945\n28893183\n15207010\n34641903\n38362471\n36872455\n21465929\n31881071\n32408900\n27429495\n36604393\n33318116\n20021682\n36651403\n38661290\n34104272\n28458801\n30178033\n26704633\n33588842\n33142711\n32669092\n36830154\n34879697\n36290076\n39159269\n27567604\n34416911\n16168785\n38457130\n38582533\n30115074\n28178770\n33072690/",
    "doi": "10.1136/bmjgh-2025-020257\n10.1093/jac/dkac255\n10.1016/S0140-6736(21)02724-0\n10.1186/s13756-021-00931-w\n10.1093/jac/dkad291\n10.1057/s41599-019-0263-4\n10.1016/S0140-6736(15)00473-0\n10.1186/s12879-017-2713-1\n10.1186/1478-4491-2-7\n10.1186/s12961-021-00748-4\n10.4314/ejhs.v33i1.1S\n10.1071/PY22052\n10.1079/9781845937454.0000\n10.1371/journal.pone.0226831\n10.1186/s12961-020-00561-5\n10.2471/BLT.15.164020\n10.1007/s10900-022-01183-4\n10.1136/bmjopen-2020-040350\n10.1186/1478-4491-7-87\n10.1590/1413-81232023282.12222022en\n10.1111/jan.16195\n10.1177/1715163521999417\n10.1101/2020.08.27.20181826\n10.4081/idr.2017.6917\n10.7326/M18-0850\n10.1016/j.puhe.2015.10.012\n10.1186/s12913-021-06122-y\n10.3390/antibiotics9110764\n10.1186/s12913-020-05512-y\n10.3390/antibiotics12020243\n10.4102/phcfm.v13i1.3107\n10.3390/antibiotics11101418\n10.1371/journal.pmed.1004416\n10.1186/s40545-021-00361-4\n10.1001/jamahealthforum.2024.0034\n10.1136/bmjopen-2023-079776\n10.1186/s12960-018-0304-x\n10.1186/s12960-017-0206-z\n10.1002/14651858.CD003543.pub4\n10.3389/fpubh.2020.493904\n10.2471/B09"
  },
  {
    "pmid": "41143081\n31908502\n39843968\n39539168\n37506486\n11990958\n38032877\n37009876\n33802546\n29090094\n39439009\n29796266\n11392867\n28459929\n38089462\n28250915\n29189034\n36309746\n1556661\n30333781\n35094640\n26078017\n38863168\n24503904\n28257511\n27094145\n39529732\n33127790\n29476032\n31758595\n39816662",
    "title": "Fostering behaviour change in farm veterinary practice: 'champion' goal-setting and implementation considerations for antimicrobial stewardship.",
    "authors": "Bard AM, Rees GM",
    "year": 2025,
    "journal": "JAC-antimicrobial resistance",
    "abstract": "The use of antimicrobials in human and animal health care settings is considered a major driving force behind the emergence of antimicrobial resistance, encouraging a focus on evidence-based interventions aimed at promoting behaviours aligned with antimicrobial stewardship (AMS) ideals within both sectors. The Arwain complex intervention within Wales established peer networks of 'Veterinary Prescribing Champions' (VPCs) within and between Welsh veterinary practices to facilitate AMS training, support and activity. This study evaluates AMS goal setting and implementation within continuously engaged Arwain veterinary practices (\nDescriptive quantitative analysis of Practice Action Plans (2020, 2024) and self-reported data on Action Plan implementation (2024), combined with qualitative analysis of participant interviews (2023) and participatory workshop feedback (2024) on challenges to implementing change, offer insight on the focus, achievements and implementation of AMS within the Arwain complex intervention.\nVPCs focused on behaviour-led (practice team/farm client) and structural (farm/practice-focused) changes. All practices reported at least one change goal initiated, with the majority (73%) reporting at least one fully implemented change. AMS implementation challenges included practical and cultural considerations of veterinary practices, the complexities of delivering AMS within inter-professional teams, the situated complexity of AMS on farm and the geographic, economic, regulatory, epidemiological and attitudinal factors implicit in the practice 'outer setting'.\nThe Arwain complex intervention led to successful implementation of AMS changes across participating practices, with varying complexity, abstractness and completeness. Further research into the impact on antimicrobial use is needed to evaluate and inform future policy.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41143081\n31908502\n39843968\n39539168\n37506486\n11990958\n38032877\n37009876\n33802546\n29090094\n39439009\n29796266\n11392867\n28459929\n38089462\n28250915\n29189034\n36309746\n1556661\n30333781\n35094640\n26078017\n38863168\n24503904\n28257511\n27094145\n39529732\n33127790\n29476032\n31758595\n39816662/",
    "doi": "10.1093/jacamr/dlaf181\n10.2147/IDR.S234610\n10.1038/s44259-024-00031-w\n10.1002/vetr.4799\n10.1016/j.socscimed.2023.116109\n10.2460/javma.2002.220.1144\n10.1016/j.jrurstud.2021.07.020\n10.1371/journal.pone.0294733\n10.1186/s13620-023-00236-x\n10.3390/antibiotics10030253\n10.1186/s13690-017-0232-6\n10.1186/s43058-024-00662-0\n10.1177/2050312118773261\n10.1037/0003-066X.55.1.68\n10.1001/jamainternmed.2017.0946\n10.1093/jacamr/dlad131\n10.1186/s13620-017-0085-x\n10.1037/ccp0000260\n10.1186/s13012-022-01245-0\n10.1037/0022-3514.62.2.292\n10.3389/fpsyg.2018.01879\n10.1080/17437199.2021.2023608\n10.12968/vetn.2011.2.7.408\n10.1017/ice.2015.136\n10.1002/vetr.4070\n10.3138/jvme.0713-095R2\n10.1371/journal.pone.0171380\n10.1016/j.prevetmed.2016.03.008\n10.1093/jacamr/dlae177\n10.1136/vr.m4135\n10.1136/vr.104701\n10.1002/gsj.1456\n10.1111/bcp.14184\n10.3389/frabi.2023.1233698"
  },
  {
    "pmid": "41142666\n21146207\n18538699\n19446918\n16722874\n29452941\n33489616\n28515903\n34430227\n31799007\n28874347\n29346620\n29643217\n31604207\n22265340\n33789754\n40571954\n38598612\n33484528\n34764659\n29306587\n34710362\n39881456\n40949784\n32497086\n35189952\n34200116\n34972026\n26029375\n12702698\n10821154\n2319282\n26962123\n26693005\n24091422\n10213583\n31282277\n32505875\n8737438\n16874650\n38198157\n15525377\n8171350\n2690414",
    "title": "Tackling the disparities in surgical site infections and related antimicrobial resistance in low- and middle-income countries.",
    "authors": "Farsakoury R, Sartelli M, Zughaier SM",
    "year": 2025,
    "journal": "Surgery in practice and science",
    "abstract": "The financial burden, morbidity, and mortality of surgical site infection (SSI) is a global issue. Incidence rates of SSI are high in low- and middle-income countries (LMICs), with evidence of surge in antimicrobial resistance (AMR) in these regions. This mini review aimed to collect and analyze existing data on SSI incidence and the associated AMR in LMICs to address some concerns about causes and control strategies.\nMEDLINE, Embase, the Cochrane Library, Scopus, AMED, Biosis, and CINAHL were all searched for this study until June 8, 2025. We included all studies comparing disparities in surgical site infections and related antimicrobial resistance in low- and middle-income countries.\nThe overall SSI incidence in LMICs is higher than in high-income countries . The intertwined relationship between SSI and the rising AMR burden further complicates the issue. The emergence of AMR is driven by inappropriate antibiotic use, poor regulatory oversight and stewardship, inadequate healthcare infrastructure, economic limitations that result in incomplete or informal treatments, weak surveillance systems, and environmental contamination from hospitals, agriculture, and wastewater. Vaccination, sanitation and hygiene, infection control, education, alternative therapies consideration of, antimicrobial stewardship, and prevention, are strategies to prevent and reduce the development of AMR.\nAMR is a dire global problem that requires immediate action to combat its spread. Effective AMR surveillance from a \"One Health\" viewpoint is needed in LMICs to map and track the spread of resistance. Environmental resistome sample is required to detect the factors influencing resistance. Searching for solution to colistin resistance, a last resort antibiotic, is critical.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41142666\n21146207\n18538699\n19446918\n16722874\n29452941\n33489616\n28515903\n34430227\n31799007\n28874347\n29346620\n29643217\n31604207\n22265340\n33789754\n40571954\n38598612\n33484528\n34764659\n29306587\n34710362\n39881456\n40949784\n32497086\n35189952\n34200116\n34972026\n26029375\n12702698\n10821154\n2319282\n26962123\n26693005\n24091422\n10213583\n31282277\n32505875\n8737438\n16874650\n38198157\n15525377\n8171350\n2690414/",
    "doi": "10.1016/j.sipas.2025.100315"
  },
  {
    "pmid": "41142507\n37823894\n30706119\n36298515\n37691049\n38330995\n38395062\n38382142\n38966853\n24499035\n28970157\n34669733\n37366804\n31023851\n30689983\n31840552\n29226070\n24461668\n24684125\n36584969\n38633223\n28941632\n30840181\n38136712\n25909312\n27098057\n36242006\n33411181\n36434539\n26112266\n34754231\n30700295\n26937222\n37998466\n36177456\n23960796\n24809678\n28002979\n27394401",
    "title": "Appropriateness of empiric antibiotic therapy for community-acquired pneumonia: A multicenter cross-sectional study.",
    "authors": "Rahme D, Chmaisse HN, Salameh P",
    "year": 2025,
    "journal": "Exploratory research in clinical and social pharmacy",
    "abstract": "Community-acquired pneumonia (CAP) remains a major public health concern, with appropriate empiric antibiotic therapy critical to improving patient outcomes and combating antimicrobial resistance (AMR). Despite the availability of national guidelines, adherence among physicians in Lebanon was previously unclear.\nTo evaluate the appropriateness of empiric antibiotic prescribing for hospitalized CAP patients in Lebanon and identify factors associated with non-compliance with national guidelines.\nA cross-sectional study was conducted in five Lebanese hospitals across various regions. Medical records of 380 adult CAP patients were reviewed. Empiric antibiotic regimens were evaluated for compliance with national CAP guidelines based on drug selection, dosage, route, and duration. Multivariate logistic regression was used to identify predictors of inappropriate prescribing.\nOnly 38.9\u00a0% of patients received fully guideline-concordant empiric therapy. Inappropriate prescribing was significantly associated with physician rank (residents: aOR\u00a0=\u00a029.13, \nNon-compliance with national CAP treatment guidelines is widespread in Lebanese hospitals and driven by physician experience, geographic disparities, and misalignment in antibiotic selection. Strengthening antimicrobial stewardship programs, regional training, and clinical decision support is essential to improve adherence and reduce AMR risk.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41142507\n37823894\n30706119\n36298515\n37691049\n38330995\n38395062\n38382142\n38966853\n24499035\n28970157\n34669733\n37366804\n31023851\n30689983\n31840552\n29226070\n24461668\n24684125\n36584969\n38633223\n28941632\n30840181\n38136712\n25909312\n27098057\n36242006\n33411181\n36434539\n26112266\n34754231\n30700295\n26937222\n37998466\n36177456\n23960796\n24809678\n28002979\n27394401/",
    "doi": "10.1016/j.rcsop.2025.100669"
  },
  {
    "pmid": "41141885\n28515903\n39104891\n31334140\n40657033\n24049221\n36702634\n39850331\n29417002\n37887197\n39156376\n39103907",
    "title": "Awareness of Antibiotic Resistance Among Medical Professionals in Kerala, India: A Cross-Sectional Study.",
    "authors": "Kuttikkunnummal AS, Sivan SP, Divakaran D, Salahudeen M, Vijay P, Theruvinkattil HJ, Usman SA",
    "year": 2025,
    "journal": "Cureus",
    "abstract": "Antimicrobial resistance (AMR) has emerged as a critical global health threat, undermining the effective treatment of infectious diseases. The growing challenge of antibiotic resistance is a matter of concern, driven by frequent misuse of antimicrobial agents and limited awareness among healthcare professionals. This study aimed to assess the level of antibiotic resistance awareness across diverse medical professionals in Kerala, India, and to identify demographic and contextual influences that affect awareness and stewardship practices.\nA cross-sectional survey was conducted among 345 healthcare professionals, including doctors, dentists, nurses, and pharmacists across Kerala. Participants completed a validated 23-item Antibiotic Resistance Awareness Scale, supplemented with modules on demographics, formal training, and workplace factors. Data were analyzed to evaluate predictors of awareness scores.\nParticipants demonstrated moderate to high overall AMR awareness (mean score 73.9 \u00b1 10.5), with the highest scores among physicians (75.8) and the lowest among nurses (69.7, p < 0.001). Significant disparities were observed by profession, training level, and practice setting. Only 23.5% reported formal AMR training, with pharmacists showing the highest training participation (44%). Males scored higher than females (mean difference 2.3, p=0.046), and practitioners in tertiary care had superior knowledge compared to those in primary care (mean difference 3.4, p=0.008). Training participation showed a positive but nonsignificant association with awareness (p=0.074).\nWhile overall awareness of antibiotic resistance among Kerala's healthcare professionals was good, substantial disparities exist, especially among nurses and those lacking formal AMR training. These findings underscore the urgent need for targeted educational programs, integrated stewardship curricula, and resource strengthening. Addressing these gaps is essential for successful AMR mitigation and for informing future policy and curricular reforms locally and in similar contexts globally.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41141885\n28515903\n39104891\n31334140\n40657033\n24049221\n36702634\n39850331\n29417002\n37887197\n39156376\n39103907/",
    "doi": "10.7759/cureus.95204"
  },
  {
    "pmid": "41141168\n30297009\n35804401\n26362293\n33012387\n28539060\n32424172\n35039180\n33144202\n37887223\n39029872\n32918445\n33602365\n38996086",
    "title": "Emerging Role of Emergency Physicians in Antimicrobial Stewardship.",
    "authors": "Taniguchi H",
    "year": 2025,
    "journal": "Cureus",
    "abstract": "The emergency department (ED) is increasingly recognized as a critical site for antimicrobial stewardship, where most initial antibiotic decisions occur, and emergency physicians (EPs), previously regarded as primarily focused on empiric treatment, are now emerging as leaders. Policy milestones, including accreditation standards and national guidelines, have catalyzed this transition, yet physician roles remain heterogeneous, and evidence on long-term outcomes is limited. Drawing on English-language literature, including intervention studies, descriptive reports, and policy documents, this editorial highlights how EPs contribute through guideline development, audit and feedback, culture follow-up, formulary oversight, rapid diagnostics, and educational initiatives. Evidence consistently shows improvements in prescribing appropriateness, reduced use of broad-spectrum agents, and faster optimization without compromising safety. However, barriers such as time pressure, professional culture, role ambiguity, and limited resources remain persistent. Importantly, the leadership of EPs has proven central in overcoming these obstacles, especially when supported by institutional commitment and integrated workflows. Their engagement is not only improving immediate prescribing practices but also represents a critical frontline defense against antimicrobial resistance and multidrug-resistant organisms. Looking forward, formalizing physician leadership, embedding stewardship in emergency medicine training, and building ED-specific data systems are essential to sustain safe and effective antibiotic use.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41141168\n30297009\n35804401\n26362293\n33012387\n28539060\n32424172\n35039180\n33144202\n37887223\n39029872\n32918445\n33602365\n38996086/",
    "doi": "10.7759/cureus.93058"
  },
  {
    "pmid": "41140110",
    "title": "Antimicrobial resistance and multidrug resistance patterns of uropathogens isolated from pregnant women with asymptomatic bacteriuria.",
    "authors": "\u00d6zt\u00fcrk C, Kara M, Akyol R, Bolacal\u0131 M",
    "year": 2025,
    "journal": "Turkish journal of obstetrics and gynecology",
    "abstract": "This study aimed to evaluate the prevalence of asymptomatic bacteriuria (ASB) in the second half of pregnancy, identify causative microorganisms, and assess their antimicrobial resistance and multidrug resistance (MDR) patterns in K\u0131r\u015fehir, T\u00fcrkiye.\nBetween April-December 2024, 182 pregnant women without urinary tract infection symptoms were screened at K\u0131r\u015fehir Training and Research Hospital. Midstream urine samples were cultured, and bacterial isolates were identified and tested for antimicrobial susceptibility using the BD Phoenix\u2122 automated system. Data were interpreted according to EUCAST 2024 criteria.\nASB prevalence was 37.36%. \nASB prevalence during second half of pregnancy was high, and a significant proportion of pathogens demonstrated MDR. The findings highlight the necessity of culture-based diagnosis and region-specific empirical therapy. High resistance to ampicillin and trimethoprim-sulfamethoxazole suggests that empirical protocols should be updated according to local antibiograms. Strengthening antibiotic stewardship and expanding routine ASB screening are critical to reducing maternal-fetal complications.\nBu \u00e7al\u0131\u015fma, gebeli\u011fin ikinci yar\u0131s\u0131nda asemptomatik bakteri\u00fcri (ASB) prevalans\u0131n\u0131 de\u011ferlendirmek, etken mikroorganizmalar\u0131 belirlemek ve bunlar\u0131n antimikrobiyal diren\u00e7 ile \u00e7oklu ila\u00e7 direnci (MDR) paternlerini incelemek amac\u0131yla K\u0131r\u015fehir, T\u00fcrkiye\u2019de ger\u00e7ekle\u015ftirilmi\u015ftir.\nGere\u00e7 ve Y\u00f6ntemler: Nisan-Aral\u0131k 2024 tarihleri aras\u0131nda, K\u0131r\u015fehir E\u011fitim ve Ara\u015ft\u0131rma Hastanesi\u2019nde \u00fcriner sistem enfeksiyonu semptomu olmayan 182 gebe kad\u0131n taranm\u0131\u015ft\u0131r. Orta ak\u0131m idrar \u00f6rnekleri k\u00fclt\u00fcre al\u0131nm\u0131\u015f, bakteri izolatlar\u0131 tan\u0131mlanm\u0131\u015f ve antimikrobiyal duyarl\u0131l\u0131k testleri BD Phoenix\u2122 otomatize sistemi ile yap\u0131lm\u0131\u015ft\u0131r. Veriler, EUCAST 2024 kriterlerine g\u00f6re yorumlanm\u0131\u015ft\u0131r.\nASB prevalans\u0131 %37,36 olarak bulunmu\u015ftur. En s\u0131k patojen \nGebeli\u011fin ikinci yar\u0131s\u0131nda ASB prevalans\u0131 y\u00fcksek olup, patojenlerin \u00f6nemli bir k\u0131sm\u0131 MDR g\u00f6stermi\u015ftir. Bulgular, k\u00fclt\u00fcr bazl\u0131 tan\u0131n\u0131n ve b\u00f6lgeye \u00f6zg\u00fc ampirik tedavi yakla\u015f\u0131mlar\u0131n\u0131n \u00f6nemini ortaya koymaktad\u0131r. Ampisilin ve trimethoprim-s\u00fclfametoksazole kar\u015f\u0131 y\u00fcksek diren\u00e7, ampirik tedavi protokollerinin yerel antibiyogramlara g\u00f6re g\u00fcncellenmesi gerekti\u011fini g\u00f6stermektedir. Antibiyotik y\u00f6netiminin g\u00fc\u00e7lendirilmesi ve rutin ASB taramalar\u0131n\u0131n yayg\u0131nla\u015ft\u0131r\u0131lmas\u0131, maternal-fetal komplikasyonlar\u0131n azalt\u0131lmas\u0131 a\u00e7\u0131s\u0131ndan kritik \u00f6neme sahiptir.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41140110/",
    "doi": "10.4274/tjod.galenos.2025.29938"
  },
  {
    "pmid": "41138520",
    "title": "Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutions.",
    "authors": "Jarrett P, Coyer FM, Long D, Roberts JA, Keogh S",
    "year": 2025,
    "journal": "Australian critical care : official journal of the Confederation of Australian Critical Care Nurses",
    "abstract": "Residual drug error (RDE) is defined as the unintentional retention of medication in intravenous delivery systems after administration. This is a growing concern in the intensive care unit (ICU), particularly in regard to antibiotics.\nThe aim of this study was to explore clinicians' awareness of RDE, its perceived causes, and potential strategies to reduce its occurrence.\nA qualitative approach using focus groups was conducted with ICU nurses, examining their awareness of RDE, contributing factors, and ideas for prevention. Thematic analysis was used to identify key themes and subthemes from the data.\nTwenty-seven participants participated in four focus groups over four mandatory training days. Clinicians' experiences with RDEs in the ICU were categorised into three main themes: (i) Awareness and perception of RDEs; (ii) Potential causes of RDE, including knowledge gaps, workload pressures, and inconsistent double-checking and documentation practices; and (iii) Proposed solutions to minimise RDEs including enhanced education, standardised protocols, and improved documentation.\nICU nurses demonstrated limited prior awareness of RDE, with participants identifying multiple contributing factors including personal practice variability, drug characteristics, workload pressures, and reconstitution technique. Proposed solutions centred on targeted education, consistent double-checking and signing procedures, and concise, accessible checklists. These findings can inform the development of practical, context-appropriate strategies to improve medication accuracy and patient safety in the ICU.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41138520/",
    "doi": "10.1016/j.aucc.2025.101450"
  },
  {
    "pmid": "41130744\n16048717\n36311485\n35065702\n38134946\n39299261\n30180122\n29744044\n30126581\n34082726\n33446266\n36035318\n36226225\n37887198\n31628999\n36945072\n31145043\n34862299\n34031643\n36211649\n38509874\n32134502\n31489183\n37291375\n32945697\n28480231\n34485504\n34620152\n30312654\n30462700\n21659004\n26242647",
    "title": "Knowledge, attitudes and practices survey on antimicrobial resistance and stewardship among pharmacy healthcare workers in 28 African countries.",
    "authors": "Agiri O, Osena G, Bahati F, Dill D, Kalanxhi E, Ashiru-Oredope D, Alimi YH",
    "year": 2025,
    "journal": "BMJ global health",
    "abstract": "Antimicrobial resistance (AMR) is a pressing global health problem disproportionately affecting low- and middle-income countries. Inappropriate antimicrobial prescription and use exacerbate AMR. This study assesses the knowledge, attitudes and practices (KAP) toward AMR and antimicrobial stewardship (AMS) among pharmacy healthcare workers involved in antimicrobial dispensing across 28 African countries.\nAn online survey was distributed to collect data on KAP from HCWs who dispense antimicrobials in African countries. Responses were scored, and a 70% cut-off mark was used to differentiate between good and poor KAP. Logistic regression analysis was used to identify factors associated with good or poor KAPs.\nA total of 2567 responses (40%) were received, of which 908 were from pharmacy HCWs who dispensed antibiotics in 28 countries. Of the 908 eligible respondents, 71.3% had good knowledge of AMR and AMS, 59.9% displayed good attitudes towards the burden of AMR and appropriate prescription of antimicrobials and 41.6% displayed good practices related to AMS. Patient demands and influence from pharmaceutical companies were among the factors that influenced the dispensing of antibiotics. In multivariable logistic regression, licensed pharmacists were more likely to have good knowledge of AMR than pharmacy technicians (adjusted OR (aOR) 1.78; 95%\u2009CI 1.64 to 1.93). Male dispensers were less likely to have a positive attitude towards AMR than female dispensers (aOR 0.69, 95%\u2009CI 0.51 to 0.94). Moreover, dispensers affiliated with public health facilities demonstrated better AMR practices than those affiliated with private facilities. Overall, good AMR knowledge status was significantly associated with positive attitudes (\u03c7\u00b2=97.1, p<0.001) and practices (\u03c7\u00b2=6.5, p<0.05) of AMR.\nThis study revealed limited understanding of AMR among dispensers without formal pharmaceutical training and a positive association between good knowledge and positive attitudes and practices. The findings underscore the importance of providing workplace educational materials on AMR and AMS to build capacity in healthcare institutions and promote proper antibiotic dispensing.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41130744\n16048717\n36311485\n35065702\n38134946\n39299261\n30180122\n29744044\n30126581\n34082726\n33446266\n36035318\n36226225\n37887198\n31628999\n36945072\n31145043\n34862299\n34031643\n36211649\n38509874\n32134502\n31489183\n37291375\n32945697\n28480231\n34485504\n34620152\n30312654\n30462700\n21659004\n26242647/",
    "doi": "10.1136/bmjgh-2025-019151\n10.1016/S1473-3099(05)70189-4\n10.1155/2022/3639943\n10.1016/S0140-6736(21)02724-0\n10.1016/S2214-109X(23)00539-9\n10.1016/S0140-6736(24)01867-1\n10.1097/PHH.0000000000000861\n10.5812/ijpbs.10242\n10.1186/s13756-018-0351-z\n10.1016/j.mcna.2018.05.009\n10.1186/s12889-021-11163-3\n10.1186/s13756-020-00880-w\n10.1093/jacamr/dlac062\n10.1093/jacamr/dlac107\n10.3390/antibiotics12101497\n10.1016/j.jgar.2019.10.007\n10.1186/s40545-023-00555-y\n10.1080/1120009X.2019.1622293\n10.1136/bmjopen-2021-054736\n10.1155/2020/5917378\n10.3389/fpubh.2022.880774\n10.1016/j.heliyon.2024.e27564\n10.1111/biom.13249\n10.7189/jogh.09.020412\n10.1007/s12325-023-02547-5\n10.1080/14787210.2021.1826307\n10.1093/ofid/ofw225\n10.4102/sajid.v36i1.262\n10.1186/s12889-021-11885-4\n10.1016/j.ijantimicag.2018.09.022\n10.1371/journal.pone.0207465\n10.1016/S1473-3099(11)70054-8\n10.1080/23120053.2016.1192808"
  },
  {
    "pmid": "41127176\n31191076\n28989448\n31179281\n30197696\n34222940\n29403295\n27994621\n38939359\n37134062\n36582301\n36798105\n31022197\n25436105\n36101578\n26901404\n12861082\n30025154\n30360517\n16142656\n11777803\n37066121\n32841415\n35453222",
    "title": "Antimicrobial perceptions and stewardship practices among community pharmacy dispensers in Nepal.",
    "authors": "Shrestha B, Shrestha S, Acharya U",
    "year": 2025,
    "journal": "Antimicrobial stewardship & healthcare epidemiology : ASHE",
    "abstract": "This study assessed the perception and practice regarding Antimicrobial Stewardship (AMS) and knowledge about antibiotics among Community Pharmacy Dispensers (CPD) in selected municipalities of Kavrepalanchowk district, Nepal.\nA cross-sectional study was conducted among CPD of the community pharmacies of Banepa, Dhulikhel, and Panauti in Kavrepalanchowk district, Nepal.\nA structured self-administered questionnaire was administered to 58 CPD selected through census sampling technique. The questionnaire comprised of questions assessing the knowledge of antibiotics, perception, and practice regarding AMS. A bivariate analysis was done to determine association between demographic variables and dependent variables.\nMajority of respondents (60.3%) had medium level of knowledge regarding antibiotics, 46.6% of the respondents had low practice scores, and 50% of the respondents had positive perceptions of AMS. A positive correlations of knowledge with perception (\nThe practice of AMS in community pharmacies is low despite of medium level of knowledge on antibiotics among the community pharmacy dispensers. Establishing AMS protocols specific to community pharmacies in Nepal can lead to standardized practices and improve adherence to AMS principles.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41127176\n31191076\n28989448\n31179281\n30197696\n34222940\n29403295\n27994621\n38939359\n37134062\n36582301\n36798105\n31022197\n25436105\n36101578\n26901404\n12861082\n30025154\n30360517\n16142656\n11777803\n37066121\n32841415\n35453222/",
    "doi": "10.1017/ash.2025.10158\n10.1093/jacamr/dlz066"
  },
  {
    "pmid": "41127156\n35065702\n37155660\n40570300\n36757700\n27080992\n28095785\n33428999\n31075400\n35062153\n29514221\n30281178\n28748196\n17923655\n29237045\n37325680\n34799064\n38089458\n25286067\n36716763",
    "title": "The relationship of prescriber training level to restricted antibiotic prescribing appropriateness at a tertiary academic hospital: a retrospective study.",
    "authors": "Greidanus P, LeBlanc RJ, Kabbani D, Smith SW, Doucette KE, Lau C, Bains S, Fong K, Stewart JJ, Zeggil T, Chen JZ",
    "year": 2025,
    "journal": "Antimicrobial stewardship & healthcare epidemiology : ASHE",
    "abstract": "This study aimed to compare appropriateness of restricted antimicrobial prescriptions, as assessed by antimicrobial stewardship program (ASP) prospective audit and feedback (PAF), between those ordered by medical trainees versus staff. Secondary objectives were to determine whether certain timing factors and other independent variables impacted prescription appropriateness.\nSingle center, retrospective cohort study.\nThe University of Alberta Hospital a 700-bed tertiary care hospital in Edmonton, Canada.\nPrescriptions of six health-authority restricted antibiotics subject to ASP PAF between 2018 and 2023. Cases were excluded if prescriber role or prescription dates or times were unavailable.\nData from a local ASP quality improvement database was extracted. Multiple logistic regression analysis was completed with adjusted odds ratios (aOR) reported.\nA total of 3,687 restricted antibiotic prescriptions subjected to PAF were included in this study, of which 1,163 (31.5%) were assessed as not appropriately prescribed. Prescriptions written by medical trainees did not have higher odds of appropriateness compared to staff (aOR 1.09 [95% CI 0.94-1.28], \nNo differences were noted in restricted antibiotic prescription appropriateness between medical trainees and staff. Weekend prescriptions were less likely to be appropriate. Improved appropriateness over time may be multifactorial, including implementation of ASP preceding the pandemic. Further studies examining timing factors associated with appropriateness are needed.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41127156\n35065702\n37155660\n40570300\n36757700\n27080992\n28095785\n33428999\n31075400\n35062153\n29514221\n30281178\n28748196\n17923655\n29237045\n37325680\n34799064\n38089458\n25286067\n36716763/",
    "doi": "10.1017/ash.2025.10185"
  },
  {
    "pmid": "41127150\n30210143\n29641617\n34971358\n30817026\n40232941\n37508288\n25521847\n25521846\n33399190\n32008696",
    "title": "How to leverage medication use evaluations for antimicrobial stewardship goals: a primer for physicians.",
    "authors": "Prasad R, Arya R, Meng L, Holubar M, Alegria W, Zimmet AN",
    "year": 2025,
    "journal": "Antimicrobial stewardship & healthcare epidemiology : ASHE",
    "abstract": "Medication Use Evaluations (MUEs) are structured quality improvement tools used to optimize medication use within healthcare systems. MUEs can explore safety concerns, high costs, or inappropriate use associated with any medication, among other factors. This can offer a valuable opportunity for Antimicrobial Stewardship Programs (ASPs) to promote stewardship goals, which often overlap with these concerns for specific antimicrobials. MUEs can also provide an avenue to promote interdisciplinary collaboration with targeted groups relevant to the ASP's goals as well as an opportunity to give trainees ownership of system-facing stewardship projects. Stewardship pharmacists may often have experience with leading this process as part of their training, but MUEs represent a gap in training for physicians. Here we provide guidance on how stewardship physicians can engage in the MUE process, from identifying relevant topics to interpreting findings and supporting implementation efforts, allowing them to contribute effectively even without prior MUE experience.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41127150\n30210143\n29641617\n34971358\n30817026\n40232941\n37508288\n25521847\n25521846\n33399190\n32008696/",
    "doi": "10.1017/ash.2025.10189\n10.1016/j.glohj.2023.02.002\n10.1177/0018578718775330\n10.1007/s40267-019-00688-8\n10.1371/journal.pone.0195434\n10.1093/cid/ciab1061\n10.1111/ctr.13512\n10.1111/ctr.70147\n10.3390/antibiotics12071192\n10.1002/phar.1506\n10.1002/phar.1515\n10.1093/ajhp/zxaa393\n10.1016/j.idc.2019.10.008"
  },
  {
    "pmid": "41126089\n32884305\n35600711\n34630834\n38107874\n31690162\n39238436\n37325582\n29921472\n31649820\n39056089\n28465825\n27933228\n26400706\n25114935\n27545670\n34157817\n39964200",
    "title": "A cross-sectional evaluation of rational antibiotic prescribing in Kabul based on WHO indicators.",
    "authors": "Ehsan H, Ibrahimkhil MA, Ahmadi M, Wardak FR, Aminpoor H, Salam A, Tariq H, Mubarak MY",
    "year": 2025,
    "journal": "BMC infectious diseases",
    "abstract": "Inappropriate antibiotic use is a major driver of antimicrobial resistance (AMR), particularly in low- and middle-income countries. To improve rational prescribing, the World Health Organization (WHO) developed core prescribing indicators and the AWaRe antibiotic classification. Evidence from Afghanistan remains scarce, especially in outpatient settings.\nThis cross-sectional prescription audit was conducted from June to December 2024 in six public and private hospitals in Kabul. Prescriptions were sampled from outpatient departments of internal medicine, pediatrics, surgery, and ENT. Of 623 prescriptions screened, 306 (49.1%) contained at least one antibiotic and were analyzed using WHO prescribing indicators and the AWaRe classification. Data were processed with SPSS v25.\nA total of 374 antibiotics were prescribed, with an average of 1.5 per prescription. The most common agents were ceftriaxone (19.9%), metronidazole (16.0%), ciprofloxacin (12.4%), and amoxicillin (11.4%). Generic prescribing accounted for 63.3%, while 42.7% of prescriptions included parenteral antibiotics. All antibiotics were from the National Essential Medicines List. AWaRe analysis showed Watch antibiotics (58.6%) predominated, while Access antibiotics (41.4%) were underused; no Reserve antibiotics were prescribed. No culture and sensitivity testing supported prescribing.\nAntibiotic prescribing in Kabul outpatient settings substantially exceeded WHO standards, with high reliance on broad-spectrum Watch-group agents, injectables, and non-generic formulations. These findings underscore the urgent need for Antimicrobial Stewardship Programs, prescriber training, and improved diagnostic capacity to ensure rational antibiotic use and contain AMR in Afghanistan.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/41126089\n32884305\n35600711\n34630834\n38107874\n31690162\n39238436\n37325582\n29921472\n31649820\n39056089\n28465825\n27933228\n26400706\n25114935\n27545670\n34157817\n39964200/",
    "doi": "10.1186/s12879-025-11826-1\n10.1002/JPER.24\u20130693"
  }
]